Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News ENDRA Life Sciences Inc NDRA

ENDRA Life Sciences Inc. is developing an enhanced ultrasound technology platform - Thermo Acoustic Enhanced Ultrasound (TAEUS), a technology which characterizes tissue similar to a magnetic resonance imaging (MRI). The Company's TAEUS technology uses radio frequency (RF) pulses to stimulate tissues, using a small fraction (less than 1%) of the amount of energy that would be transmitted into... see more

Recent & Breaking News (NDAQ:NDRA)

ENDRA Life Sciences Granted Additional European Patent As Commercialization Begins

Accesswire July 22, 2020

ENDRA Life Sciences Expands Global Technology Protection With New Chinese Patents

Accesswire July 13, 2020

ENDRA Life Sciences Submits 510(k) Application to the US FDA for TAEUS(R) Liver Device

Accesswire June 30, 2020

ENDRA Life Sciences Expands IP Portfolio to 72 with Addition of Key Patents

Accesswire June 23, 2020

ENDRA Life Sciences to Present at the 2020 Virtual Summer Summit

Accesswire June 8, 2020

ENDRA Life Sciences Announces New Clinical Study Partnership with the Medical College of Wisconsin (MCW)

Accesswire June 8, 2020

47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th

Accesswire June 3, 2020

ENDRA Life Sciences Provides Business Update and Reports First Quarter 2020 Financial Results

Accesswire May 14, 2020

ENDRA Life Sciences Strengthens IP Portfolio with Issuance of Additional Patents for its Innovative Fatty Liver Imaging Probe

Accesswire May 6, 2020

ENDRA Life Sciences to Host First Quarter 2020 Financial Results Conference Call and Webcast on Thursday, May 14, 2020 at 4:30 p.m. ET

Accesswire May 1, 2020

ENDRA Life Sciences Builds on CE Mark Approval

Accesswire April 30, 2020

ENDRA Life Sciences Announces Cash Strategy and Business Update in Response to COVID-19

Accesswire April 13, 2020

ENDRA Life Sciences Provides Business Update and Reports Fourth Quarter and Full Year 2019 Financial Results

Accesswire March 26, 2020

ENDRA Life Sciences Provides Update on FDA Regulatory Timeline

Accesswire March 19, 2020

ENDRA Life Sciences Provides European Commercialization Update

Accesswire March 17, 2020

ENDRA Life Sciences Receives CE Mark for its TAEUS(R) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease

Accesswire March 10, 2020

ENDRA Life Sciences to Host Fourth Quarter 2019 Financial Results Conference Call and Webcast on Thursday, March 26, 2020 at 4:30 p.m. ET

Accesswire March 9, 2020

ENDRA Life Sciences Granted Chinese Patent for "Thermoacoustic Imaging Probe"

Accesswire March 6, 2020

Dr. Raza Malik joins ENDRA Life Sciences as Scientific Advisor

Accesswire March 3, 2020

ENDRA Life Sciences Renews GE Healthcare Collaboration Agreement

Accesswire January 15, 2020